Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $8.45 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.97.
Market Cap
8.45T
Revenue
4.59T
Profits
201.33B
PE Ratio
41.97
Profit Margin
4.39%
Dividend Yield
0.43%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | 0.55% | 4,125,583 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 560.33B | 2.02% | 8,034,468 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 401.47B | 1.02% | 6,248,114 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 362.78B | 0.76% | 10,897,297 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 298.33B | 0.44% | 15,966,014 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 287.50B | 2.28% | 2,346,176 | 60.44B |
| 7 | NVS | Novartis AG | 271.79B | 0.51% | 3,570,530 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 195.68B | -1.81% | 10,855,333 | 50.57B |
| 9 | AMGN | Amgen Inc. | 188.67B | 1.15% | 3,451,239 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 175.70B | -1.91% | 1,728,124 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 160.36B | -0.02% | 15,369,358 | 29.74B |
| 12 | ABT | Abbott Laboratories | 158.63B | 0.32% | 11,925,522 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 149.48B | 0.77% | 2,775,558 | 10.58B |
| 14 | PFE | Pfizer Inc. | 148.41B | 1.36% | 32,218,335 | 63.32B |
| 15 | DHR | Danaher Corporation | 130.44B | -1.25% | 3,305,485 | 24.78B |
| 16 | CVS | CVS Health Corporation | 122.40B | 1.17% | 9,704,796 | 405.62B |
| 17 | SYK | Stryker Corporation | 117.18B | 1.48% | 2,123,089 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 116.95B | 1.18% | 9,573,148 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 113.41B | 1.15% | 1,530,182 | 12.22B |
| 20 | SNY | Sanofi | 108.03B | 1.44% | 2,440,343 | 54.60B |
| 21 | MDT | Medtronic plc | 104.85B | -0.32% | 15,284,353 | 36.36B |
| 22 | GSK | GSK plc | 103.48B | 0.49% | 4,048,087 | 43.29B |
| 23 | MCK | McKesson Corporation | 93.24B | 2.47% | 981,990 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 90.24B | 1.49% | 1,739,303 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 82.55B | 2.85% | 2,185,782 | 76.39B |
| 26 | CI | The Cigna Group | 76.58B | 3.14% | 1,704,080 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 72.16B | -0.61% | 20,253,602 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 64.65B | 1.07% | 975,365 | 14.92B |
| 29 | ARGX | argenx SE | 55.01B | 5.82% | 795,682 | 4.74B |
| 30 | COR | Cencora, Inc. | 53.51B | 1.75% | 1,318,997 | 328.68B |
| 31 | EW | Edwards Lifesciences Corporation | 49.50B | -1.70% | 5,778,950 | 6.30B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 48.56B | 0.97% | 3,514,871 | 28.34B |
| 33 | CAH | Cardinal Health, Inc. | 48.18B | 1.97% | 1,590,849 | 250.74B |
| 34 | IDXX | IDEXX Laboratories, Inc. | 44.34B | -0.46% | 459,046 | 4.45B |
| 35 | MDLN | Medline Inc. | 44.15B | -2.44% | 7,570,362 | 29.14B |
| 36 | HUM | Humana Inc. | 42.03B | 0.08% | 1,739,360 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 41.65B | 1.07% | 2,077,085 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.46B | -0.19% | 1,004,444 | 4.29B |
| 39 | HLN | Haleon plc | 39.94B | 1.79% | 10,666,998 | 14.85B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 39.81B | -0.70% | 5,713,369 | 17.35B |
| 41 | A | Agilent Technologies, Inc. | 38.25B | -2.12% | 2,201,123 | 7.23B |
| 42 | WAT | Waters Corporation | 35.87B | -2.95% | 676,514 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.30B | -0.10% | 5,327,003 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.60B | 0.35% | 1,356,026 | 10.63B |
| 45 | RPRX | Royalty Pharma plc | 32.17B | 1.54% | 6,027,381 | 2.44B |
| 46 | RVMD | Revolution Medicines, Inc. | 31.73B | -4.15% | 2,140,219 | - |
| 47 | NTRA | Natera, Inc. | 30.84B | -3.06% | 847,664 | 2.50B |
| 48 | CNC | Centene Corporation | 30.78B | -0.59% | 3,961,109 | 178.33B |
| 49 | IQV | IQVIA Holdings Inc. | 30.62B | -1.84% | 1,279,041 | 16.63B |
| 50 | ONC | BeOne Medicines AG | 30.03B | -3.51% | 325,946 | 5.70B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.42B | 1.35% | 4,930,739 | 20.98B |
| 52 | BIIB | Biogen Inc. | 28.84B | -0.57% | 880,369 | 9.94B |
| 53 | RMD | ResMed Inc. | 28.31B | 0.89% | 1,536,297 | 5.54B |
| 54 | VEEV | Veeva Systems Inc. | 28.17B | -3.35% | 2,500,325 | 3.32B |
| 55 | DXCM | DexCom, Inc. | 28.11B | 0.37% | 4,859,299 | 4.82B |
| 56 | PHG | Koninklijke Philips N.V. | 24.99B | 0.46% | 1,197,520 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.56B | -3.42% | 2,061,540 | 4.39B |
| 58 | UTHR | United Therapeutics Corporation | 23.34B | 0.40% | 663,249 | 3.17B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.33B | -2.22% | 255,120 | 4.09B |
| 60 | BNTX | BioNTech SE | 22.27B | -1.69% | 837,342 | 3.23B |
| 61 | WST | West Pharmaceutical Services, Inc. | 22.22B | -0.89% | 636,032 | 3.22B |
| 62 | DGX | Quest Diagnostics Incorporated | 22.17B | 2.13% | 815,987 | 11.28B |
| 63 | LH | Labcorp Holdings Inc. | 21.74B | 1.60% | 429,275 | 14.14B |
| 64 | STE | STERIS plc | 20.73B | 0.05% | 1,132,599 | 5.94B |
| 65 | ROIV | Roivant Sciences Ltd. | 20.56B | -3.22% | 4,643,231 | 8.26M |
| 66 | INCY | Incyte Corporation | 20.45B | 1.13% | 2,641,263 | 5.36B |
| 67 | INSM | Insmed Incorporated | 20.42B | -10.20% | 7,956,670 | 819.56M |
| 68 | MRNA | Moderna, Inc. | 18.82B | -8.04% | 6,084,113 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.49B | -0.13% | 8,981,405 | 14.56B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 16.90B | 0.74% | 1,963,608 | 8.41B |
| 71 | GH | Guardant Health, Inc. | 16.66B | -5.60% | 3,345,388 | 1.08B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.48B | -2.07% | 1,050,080 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.12B | 1.70% | 2,085,794 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 14.97B | -0.62% | 677,984 | 4.44B |
| 75 | SOLV | Solventum Corporation | 14.03B | -1.71% | 1,726,800 | 8.26B |
| 76 | THC | Tenet Healthcare Corporation | 13.96B | 0.43% | 1,029,209 | 21.46B |
| 77 | EXEL | Exelixis, Inc. | 13.25B | 0.40% | 2,161,807 | 2.38B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.24B | 0.42% | 2,589,974 | 579.96M |
| 79 | COO | The Cooper Companies, Inc. | 13.14B | 8.58% | 9,090,870 | 4.23B |
| 80 | SNN | Smith & Nephew plc | 13.10B | -0.78% | 1,750,421 | 6.16B |
| 81 | ASND | Ascendis Pharma A/S | 13.07B | -3.83% | 592,713 | 998.25M |
| 82 | MEDP | Medpace Holdings, Inc. | 12.97B | -0.97% | 190,541 | 2.68B |
| 83 | PEN | Penumbra, Inc. | 12.61B | -0.03% | 278,756 | 1.45B |
| 84 | DVA | DaVita Inc. | 12.34B | -0.01% | 624,245 | 13.84B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.31B | -0.87% | 1,981,992 | 1.06B |
| 86 | ALGN | Align Technology, Inc. | 12.01B | -0.33% | 494,434 | 4.10B |
| 87 | AXSM | Axsome Therapeutics, Inc. | 11.96B | 0.36% | 1,118,650 | 708.24M |
| 88 | FMS | Fresenius Medical Care AG | 11.84B | 0.46% | 554,177 | 22.32B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 11.80B | - | 8,013,784 | 13.65B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.80B | -4.37% | 4,214,528 | 4.89B |
| 91 | SMMT | Summit Therapeutics Inc. | 11.46B | -0.47% | 6,516,515 | - |
| 92 | ICLR | ICON Public Limited Company | 11.44B | -2.19% | 1,348,933 | 8.25B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.23B | -1.19% | 187,088 | 1.13B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.17B | - | 1,092,539 | 3.58B |
| 95 | RVTY | Revvity, Inc. | 10.97B | -3.94% | 868,561 | 2.90B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.97B | 0.53% | 2,232,610 | 3.24B |
| 97 | GMED | Globus Medical, Inc. | 10.86B | - | 1,595,461 | 3.10B |
| 98 | PODD | Insulet Corporation | 10.61B | 4.65% | 2,307,227 | 2.90B |
| 99 | EHC | Encompass Health Corporation | 10.32B | 4.18% | 684,051 | 6.07B |
| 100 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.30B | -2.75% | 1,227,702 | 622.01M |
| 101 | BAX | Baxter International Inc. | 10.01B | 0.16% | 6,837,182 | 11.32B |
| 102 | MOH | Molina Healthcare, Inc. | 9.94B | -1.01% | 664,892 | 43.10B |
| 103 | RGC | Regencell Bioscience Holdings Limited | 9.90B | -9.79% | 101,876 | - |
| 104 | ENSG | The Ensign Group, Inc. | 9.87B | 3.66% | 478,601 | 5.27B |
| 105 | CYTK | Cytokinetics, Incorporated | 9.70B | -1.12% | 1,614,067 | 105.82M |
| 106 | MASI | Masimo Corporation | 9.36B | -0.04% | 630,224 | 1.56B |
| 107 | KRYS | Krystal Biotech, Inc. | 8.87B | -2.21% | 264,455 | 417.30M |
| 108 | HSIC | Henry Schein, Inc. | 8.82B | 1.51% | 1,285,160 | 13.38B |
| 109 | UHS | Universal Health Services, Inc. | 8.79B | 1.72% | 1,330,698 | 17.76B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.73B | -2.40% | 519,308 | 4.03B |
| 111 | BRKR | Bruker Corporation | 8.58B | -5.97% | 3,588,185 | 3.46B |
| 112 | HALO | Halozyme Therapeutics, Inc. | 8.48B | -0.10% | 1,144,090 | 1.51B |
| 113 | TEM | Tempus AI, Inc. | 8.34B | -11.16% | 8,873,366 | 1.36B |
| 114 | TECH | Bio-Techne Corporation | 8.14B | -2.24% | 2,947,830 | 1.21B |
| 115 | ABVX | ABIVAX Société Anonyme | 8.08B | -3.24% | 2,625,137 | 5.67M |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 7.88B | -4.28% | 346,881 | 2.59B |
| 117 | CORT | Corcept Therapeutics Incorporated | 7.80B | -3.03% | 774,655 | 769.10M |
| 118 | QGEN | Qiagen N.V. | 7.59B | -2.34% | 1,412,829 | 2.10B |
| 119 | HQY | HealthEquity, Inc. | 7.41B | 3.07% | 769,971 | 1.34B |
| 120 | OSCR | Oscar Health, Inc. | 7.38B | 3.86% | 9,384,574 | 13.30B |
| 121 | GKOS | Glaukos Corporation | 7.34B | 2.72% | 1,444,705 | 551.35M |
| 122 | IBRX | ImmunityBio, Inc. | 7.25B | -5.08% | 13,818,425 | 140.98M |
| 123 | ATR | AptarGroup, Inc. | 7.23B | 0.72% | 466,264 | 3.87B |
| 124 | NUVL | Nuvalent, Inc. | 7.18B | -3.27% | 715,982 | - |
| 125 | ALKS | Alkermes plc | 7.13B | -1.34% | 1,312,010 | 1.56B |
| 126 | PRAX | Praxis Precision Medicines, Inc. | 7.08B | -4.06% | 617,734 | 7.46M |
| 127 | RGEN | Repligen Corporation | 6.90B | -3.35% | 676,034 | 763.34M |
| 128 | PCVX | Vaxcyte, Inc. | 6.84B | -2.87% | 1,106,310 | - |
| 129 | LNTH | Lantheus Holdings, Inc. | 6.57B | -1.79% | 746,230 | 1.55B |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.51B | -4.38% | 1,308,160 | - |
| 131 | GRFS | Grifols, S.A. | 6.41B | 0.79% | 338,351 | 8.58B |
| 132 | SYRE | Spyre Therapeutics, Inc. | 6.40B | -6.15% | 1,479,790 | - |
| 133 | IMVT | Immunovant, Inc. | 6.39B | -4.78% | 872,045 | - |
| 134 | PTGX | Protagonist Therapeutics, Inc. | 6.26B | -5.26% | 887,387 | 74.06M |
| 135 | AVTR | Avantor, Inc. | 6.25B | -3.78% | 9,530,301 | 6.55B |
| 136 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.45% | 1,702,171 | 15.00M |
| 137 | KYMR | Kymera Therapeutics, Inc. | 6.10B | -0.64% | 639,318 | 51.48M |
| 138 | HIMS | Hims & Hers Health, Inc. | 6.06B | -6.50% | 18,705,868 | 2.37B |
| 139 | LEGN | Legend Biotech Corporation | 6.06B | -4.62% | 2,484,726 | 1.14B |
| 140 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.92B | -1.38% | 417,777 | 217.17M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.89B | 0.47% | 937,025 | 827.11M |
| 142 | PACS | PACS Group, Inc. | 5.86B | -1.23% | 637,783 | 5.43B |
| 143 | CHE | Chemed Corporation | 5.84B | 2.14% | 218,981 | 2.54B |
| 144 | TFX | Teleflex Incorporated | 5.75B | -1.72% | 723,524 | 2.13B |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 5.70B | 1.07% | 585,272 | 569.61M |
| 146 | TGTX | TG Therapeutics, Inc. | 5.69B | -0.99% | 1,790,281 | 700.35M |
| 147 | BLTE | Belite Bio, Inc | 5.64B | -0.77% | 333,834 | - |
| 148 | BLCO | Bausch + Lomb Corporation | 5.51B | 0.72% | 585,322 | 5.21B |
| 149 | LQDA | Liquidia Corporation | 5.50B | -1.10% | 1,701,167 | 288.07M |
| 150 | SRRK | Scholar Rock Holding Corporation | 5.31B | -2.27% | 1,153,268 | - |
| 151 | COGT | Cogent Biosciences, Inc. | 5.30B | -5.40% | 1,795,094 | - |
| 152 | STVN | Stevanato Group S.p.A. | 5.04B | -0.27% | 354,168 | 1.39B |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.00B | -2.38% | 1,687,602 | 7.50M |
| 154 | CRSP | CRISPR Therapeutics AG | 5.00B | -8.97% | 2,296,747 | 4.10M |
| 155 | HNGE | Hinge Health, Inc. | 4.92B | 1.02% | 2,408,189 | 646.34M |
| 156 | LGND | Ligand Pharmaceuticals Incorporated | 4.75B | 0.46% | 174,942 | 274.48M |
| 157 | CGON | CG Oncology, Inc. | 4.74B | -4.23% | 951,497 | 5.07M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.66B | -4.57% | 2,737,711 | 907.29M |
| 159 | BLLN | BillionToOne, Inc. | 4.47B | -7.08% | 879,535 | 354.54M |
| 160 | SHC | Sotera Health Company | 4.45B | 0.32% | 2,092,471 | 1.19B |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 4.40B | -4.30% | 835,881 | 1.34M |
| 162 | AMRX | Amneal Pharmaceuticals, Inc. | 4.39B | 1.70% | 1,294,956 | 3.05B |
| 163 | TWST | Twist Bioscience Corporation | 4.31B | -6.37% | 2,474,171 | 409.48M |
| 164 | CELC | Celcuity Inc. | 4.31B | -4.53% | 1,687,134 | - |
| 165 | RDNT | RadNet, Inc. | 4.27B | 2.90% | 960,545 | 2.14B |
| 166 | TVTX | Travere Therapeutics, Inc. | 4.26B | -0.80% | 2,892,431 | 536.20M |
| 167 | MMED | MiniMed Group, Inc. | 4.00B | 1.21% | 457,565 | 3.10B |
| 168 | LIVN | LivaNova PLC | 3.97B | -1.84% | 412,847 | 1.43B |
| 169 | TXG | 10x Genomics, Inc. | 3.94B | -7.34% | 3,801,700 | 638.78M |
| 170 | VCYT | Veracyte, Inc. | 3.89B | -2.42% | 1,168,485 | 541.74M |
| 171 | MMSI | Merit Medical Systems, Inc. | 3.85B | 2.28% | 710,917 | 1.54B |
| 172 | WAY | Waystar Holding Corp. | 3.84B | -1.09% | 1,216,316 | 1.16B |
| 173 | MANE | Veradermics, Incorporated | 3.83B | -9.42% | 548,758 | - |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 3.83B | -4.41% | 2,961,860 | - |
| 175 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | -0.06% | 1,533,608 | 596.96M |
| 176 | DOCS | Doximity, Inc. | 3.77B | -0.53% | 2,437,486 | 644.86M |
| 177 | NVST | Envista Holdings Corporation | 3.76B | 1.01% | 2,750,252 | 2.81B |
| 178 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.73B | -1.65% | 344,545 | 754.05M |
| 179 | ERAS | Erasca, Inc. | 3.72B | -9.80% | 6,143,949 | - |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.69B | -0.74% | 807,264 | 1.10B |
| 181 | NAMS | NewAmsterdam Pharma Company N.V. | 3.68B | -3.52% | 1,108,372 | 22.57M |
| 182 | ORKA | Oruka Therapeutics, Inc. | 3.63B | -3.44% | 1,301,594 | - |
| 183 | IRTC | iRhythm Holdings, Inc. | 3.55B | 0.68% | 556,010 | 787.85M |
| 184 | OGN | Organon & Co. | 3.51B | -0.30% | 2,188,256 | 6.16B |
| 185 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.47B | -4.94% | 863,218 | 18.07M |
| 186 | ICUI | ICU Medical, Inc. | 3.42B | 1.27% | 269,849 | 2.16B |
| 187 | VKTX | Viking Therapeutics, Inc. | 3.30B | -4.47% | 2,738,745 | - |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 3.24B | 1.61% | 583,614 | 2.23B |
| 189 | HAE | Haemonetics Corporation | 3.24B | 2.05% | 604,790 | 1.33B |
| 190 | OPCH | Option Care Health, Inc. | 3.22B | 2.34% | 2,646,457 | 5.67B |
| 191 | TLX | Telix Pharmaceuticals Limited | 3.19B | -2.52% | 262,827 | 803.79M |
| 192 | ALHC | Alignment Healthcare, Inc. | 3.18B | 1.99% | 4,302,072 | 4.26B |
| 193 | ITGR | Integer Holdings Corporation | 3.12B | -0.82% | 248,493 | 1.86B |
| 194 | DNLI | Denali Therapeutics Inc. | 3.10B | -3.08% | 2,192,211 | - |
| 195 | NHC | National HealthCare Corporation | 3.00B | 2.19% | 105,788 | 1.53B |
| 196 | RLAY | Relay Therapeutics, Inc. | 2.95B | -7.02% | 6,071,411 | 10.68M |
| 197 | BKD | Brookdale Senior Living Inc. | 2.95B | 3.78% | 4,300,233 | 3.00B |
| 198 | BEAM | Beam Therapeutics Inc. | 2.93B | -10.48% | 2,365,228 | 164.01M |
| 199 | TNGX | Tango Therapeutics, Inc. | 2.92B | -8.71% | 4,017,887 | 56.99M |
| 200 | RCUS | Arcus Biosciences, Inc. | 2.92B | -6.08% | 1,035,801 | 236.00M |
| 201 | LFST | LifeStance Health Group, Inc. | 2.87B | -3.01% | 1,924,023 | 1.49B |
| 202 | DYN | Dyne Therapeutics, Inc. | 2.82B | -7.44% | 1,882,591 | - |
| 203 | WRBY | Warby Parker Inc. | 2.79B | -5.80% | 2,570,005 | 890.57M |
| 204 | PRVA | Privia Health Group, Inc. | 2.73B | 1.22% | 910,554 | 2.25B |
| 205 | ADPT | Adaptive Biotechnologies Corporation | 2.70B | -6.53% | 2,164,035 | 295.41M |
| 206 | GPCR | Structure Therapeutics Inc. | 2.67B | -3.79% | 515,293 | - |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 2.66B | -3.28% | 1,209,409 | 415.62M |
| 208 | SUPN | Supernus Pharmaceuticals, Inc. | 2.60B | 0.13% | 552,808 | 776.83M |
| 209 | GRAL | GRAIL, Inc. | 2.57B | -9.87% | 760,274 | 156.12M |
| 210 | DFTX | Definium Therapeutics, Inc. | 2.57B | -4.23% | 4,182,132 | - |
| 211 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | -0.78% | 445,268 | 1.46B |
| 212 | IRON | Disc Medicine, Inc. | 2.56B | -5.78% | 454,504 | - |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.55B | -1.76% | 370,081 | 535.08M |
| 214 | KLRA | Kailera Therapeutics, Inc. | 2.51B | -7.72% | 450,718 | - |
| 215 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | -3.18% | 710,868 | 225.27M |
| 216 | GMRS | GMR Solutions Inc. | 2.43B | -0.64% | 761,050 | 5.74B |
| 217 | ALMS | Alumis Inc. | 2.43B | -6.52% | 1,436,419 | 8.40M |
| 218 | HTFL | HeartFlow, Inc. | 2.42B | -2.46% | 730,448 | 191.42M |
| 219 | TMDX | TransMedics Group, Inc. | 2.40B | -2.72% | 1,042,935 | 635.89M |
| 220 | VERA | Vera Therapeutics, Inc. | 2.32B | -3.27% | 1,515,652 | - |
| 221 | AXGN | Axogen, Inc. | 2.28B | 0.97% | 817,344 | 238.11M |
| 222 | ACHC | Acadia Healthcare Company, Inc. | 2.25B | -2.90% | 2,509,913 | 3.37B |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.25B | -4.38% | 1,273,287 | 865.00K |
| 224 | PBH | Prestige Consumer Healthcare Inc. | 2.24B | 3.83% | 507,410 | 1.09B |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.19B | -2.85% | 359,196 | 229.58M |
| 226 | PHVS | Pharvaris N.V. | 2.17B | -1.71% | 775,064 | - |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.16B | 0.98% | 244,135 | 256.28M |
| 228 | RARE | Ultragenyx Pharmaceutical Inc. | 2.15B | -6.01% | 1,117,021 | 670.00M |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.14B | -0.71% | 2,500,810 | 885.72M |
| 230 | ELVN | Enliven Therapeutics, Inc. | 2.11B | -2.20% | 1,076,325 | - |
| 231 | IMNM | Immunome, Inc. | 2.10B | -5.59% | 895,711 | 4.02M |
| 232 | SEM | Select Medical Holdings Corporation | 2.05B | 0.30% | 465,090 | 5.52B |
| 233 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -3.24% | 1,275,206 | 298.30M |
| 234 | PGNY | Progyny, Inc. | 2.03B | 1.49% | 1,229,200 | 1.29B |
| 235 | CLOV | Clover Health Investments, Corp. | 2.02B | -4.01% | 4,783,657 | 2.21B |
| 236 | BHC | Bausch Health Companies Inc. | 2.01B | 2.09% | 1,840,592 | 10.53B |
| 237 | XRAY | DENTSPLY SIRONA Inc. | 2.00B | 1.21% | 3,469,293 | 3.68B |
| 238 | NVCR | NovoCure Limited | 1.99B | -4.61% | 2,168,013 | 674.41M |
| 239 | OMCL | Omnicell, Inc. | 1.96B | -1.38% | 337,278 | 1.23B |
| 240 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | -5.43% | 4,182,879 | - |
| 241 | KOD | Kodiak Sciences Inc. | 1.94B | -9.10% | 1,450,411 | - |
| 242 | NEOG | Neogen Corporation | 1.94B | -2.41% | 1,495,545 | 870.56M |
| 243 | NKTR | Nektar Therapeutics | 1.94B | -3.36% | 1,033,573 | 55.63M |
| 244 | TRVI | Trevi Therapeutics, Inc. | 1.89B | -4.31% | 729,270 | - |
| 245 | NTLA | Intellia Therapeutics, Inc. | 1.89B | -8.20% | 7,484,158 | 66.09M |
| 246 | IOVA | Iovance Biotherapeutics, Inc. | 1.89B | -3.42% | 19,691,194 | 285.61M |
| 247 | ASTH | Astrana Health, Inc. | 1.88B | 0.40% | 632,845 | 3.53B |
| 248 | MESO | Mesoblast Limited | 1.88B | -6.56% | 260,738 | 65.38M |
| 249 | STOK | Stoke Therapeutics, Inc. | 1.87B | -0.37% | 569,515 | 32.08M |
| 250 | ZLAB | Zai Lab Limited | 1.87B | -4.15% | 1,694,977 | 453.28M |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | -2.31% | 461,366 | 899.11M |
| 252 | HCM | HUTCHMED (China) Limited | 1.86B | -2.69% | 120,950 | 548.51M |
| 253 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -0.32% | 138,611 | 1.20B |
| 254 | VCEL | Vericel Corporation | 1.85B | 1.71% | 558,316 | 292.09M |
| 255 | ADMA | ADMA Biologics, Inc. | 1.85B | -0.13% | 2,496,058 | 509.86M |
| 256 | NBTX | Nanobiotix S.A. | 1.81B | -3.96% | 49,645 | 38.27M |
| 257 | MD | Pediatrix Medical Group, Inc. | 1.81B | 1.07% | 461,478 | 1.93B |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.81B | -6.25% | 1,348,699 | 52.04M |
| 259 | SGRY | Surgery Partners, Inc. | 1.78B | 0.22% | 906,152 | 3.34B |
| 260 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -12.76% | 26,943,925 | 66.41M |
| 261 | ZYME | Zymeworks Inc. | 1.76B | -4.22% | 464,815 | 81.26M |
| 262 | PLSE | Pulse Biosciences, Inc. | 1.75B | -5.98% | 315,333 | 751.00K |
| 263 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -4.77% | 1,783,375 | 70.92M |
| 264 | UFPT | UFP Technologies, Inc. | 1.73B | -0.24% | 240,003 | 608.85M |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.73B | -3.71% | 181,278 | 20.00M |
| 266 | ANIP | ANI Pharmaceuticals, Inc. | 1.72B | 2.41% | 338,183 | 923.71M |
| 267 | ABCL | AbCellera Biologics Inc. | 1.72B | -11.77% | 8,927,909 | 79.21M |
| 268 | ADUS | Addus HomeCare Corporation | 1.68B | 2.68% | 179,245 | 1.45B |
| 269 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | -1.74% | 561,318 | 66.05M |
| 270 | NUVB | Nuvation Bio Inc. | 1.68B | -6.77% | 3,476,129 | 143.05M |
| 271 | QURE | uniQure N.V. | 1.67B | -5.50% | 1,451,330 | 18.09M |
| 272 | SRPT | Sarepta Therapeutics, Inc. | 1.66B | -5.46% | 2,739,948 | 2.18B |
| 273 | INVA | Innoviva, Inc. | 1.66B | 1.62% | 845,393 | 420.69M |
| 274 | GENB | Generate Biomedicines, Inc. | 1.65B | -12.45% | 1,637,192 | 30.30M |
| 275 | AAPG | Ascentage Pharma Group International | 1.64B | -5.91% | 13,596 | 82.08M |
| 276 | CMPS | COMPASS Pathways plc | 1.63B | -7.20% | 4,270,290 | - |
| 277 | BHVN | Biohaven Ltd. | 1.63B | -5.26% | 2,035,754 | - |
| 278 | AGL | agilon health, inc. | 1.62B | 1.70% | 215,169 | 5.82B |
| 279 | SNDA | Sonida Senior Living, Inc. | 1.60B | 3.65% | 472,363 | 367.34M |
| 280 | SION | Sionna Therapeutics, Inc. | 1.60B | -6.38% | 461,279 | - |
| 281 | TYRA | Tyra Biosciences, Inc. | 1.58B | -1.99% | 1,454,893 | - |
| 282 | PRCT | PROCEPT BioRobotics Corporation | 1.58B | 3.07% | 1,059,403 | 322.02M |
| 283 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | -6.62% | 1,360,962 | 7.47M |
| 284 | NVAX | Novavax, Inc. | 1.56B | -6.87% | 4,583,764 | 596.34M |
| 285 | PVLA | Palvella Therapeutics, Inc. | 1.56B | -5.36% | 374,164 | - |
| 286 | WGS | GeneDx Holdings Corp. | 1.55B | -7.22% | 1,182,402 | 442.68M |
| 287 | CAPR | Capricor Therapeutics, Inc. | 1.55B | -4.44% | 578,218 | 11.13M |
| 288 | SNDX | Syndax Pharmaceuticals, Inc. | 1.54B | -3.77% | 2,702,442 | 217.17M |
| 289 | SLS | SELLAS Life Sciences Group, Inc. | 1.53B | -8.96% | 6,720,893 | - |
| 290 | FTRE | Fortrea Holdings Inc. | 1.52B | -6.78% | 1,033,235 | 2.71B |
| 291 | NRIX | Nurix Therapeutics, Inc. | 1.51B | -4.19% | 1,633,069 | 71.78M |
| 292 | PRGO | Perrigo Company plc | 1.50B | 1.50% | 2,999,240 | 4.18B |
| 293 | STAA | STAAR Surgical Company | 1.49B | 0.44% | 566,592 | 290.38M |
| 294 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.48B | -6.92% | 1,738,328 | -665.00K |
| 295 | GHRS | GH Research PLC | 1.47B | -7.83% | 352,033 | - |
| 296 | ANAB | AnaptysBio, Inc. | 1.47B | -2.52% | 612,019 | 232.39M |
| 297 | VIR | Vir Biotechnology, Inc. | 1.46B | -5.46% | 1,327,726 | 65.50M |
| 298 | AVAH | Aveanna Healthcare Holdings Inc. | 1.45B | 0.75% | 1,802,271 | 2.52B |
| 299 | ATAI | AtaiBeckley Inc. | 1.45B | -12.22% | 9,240,989 | 3.49M |
| 300 | MBX | MBX Biosciences, Inc. | 1.44B | -2.04% | 580,356 | - |
| 301 | IMCR | Immunocore Holdings plc | 1.44B | -1.63% | 282,085 | 412.81M |
| 302 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | - | 1,834,277 | 114.48M |
| 303 | ALMR | Alamar Biosciences, Inc. | 1.42B | -4.42% | 280,023 | 87.16M |
| 304 | NEO | NeoGenomics, Inc. | 1.42B | -3.63% | 1,047,127 | 745.97M |
| 305 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -8.28% | 634,862 | - |
| 306 | SEPN | Septerna, Inc. | 1.40B | -0.70% | 211,653 | 72.26M |
| 307 | HCSG | Healthcare Services Group, Inc. | 1.40B | -0.39% | 516,765 | 1.85B |
| 308 | GLUE | Monte Rosa Therapeutics, Inc. | 1.38B | -5.70% | 950,289 | 42.95M |
| 309 | ARDX | Ardelyx, Inc. | 1.37B | 2.96% | 4,589,691 | 427.68M |
| 310 | ATRC | AtriCure, Inc. | 1.37B | -0.62% | 523,524 | 552.16M |
| 311 | ENOV | Enovis Corporation | 1.37B | 4.02% | 709,587 | 2.28B |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.34B | -4.45% | 445,614 | 20.00M |
| 313 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | -0.57% | 2,305,399 | 1.03B |
| 314 | IART | Integra LifeSciences Holdings Corporation | 1.32B | -3.25% | 867,925 | 1.64B |
| 315 | MLTX | MoonLake Immunotherapeutics | 1.32B | -4.38% | 538,485 | - |
| 316 | AHCO | AdaptHealth Corp. | 1.32B | 1.64% | 920,372 | 3.29B |
| 317 | PAHC | Phibro Animal Health Corporation | 1.32B | -1.85% | 271,467 | 1.50B |
| 318 | BCAX | Bicara Therapeutics Inc. | 1.31B | -2.01% | 356,197 | - |
| 319 | IMTX | Immatics N.V. | 1.31B | -3.83% | 1,129,261 | 43.00M |
| 320 | URGN | UroGen Pharma Ltd. | 1.31B | -2.72% | 704,098 | 140.49M |
| 321 | BLFS | BioLife Solutions, Inc. | 1.30B | -1.62% | 701,948 | 101.66M |
| 322 | DMRA | Damora Therapeutics, Inc. | 1.30B | -5.56% | 523,534 | - |
| 323 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.30B | 0.60% | 2,270,168 | 204.73M |
| 324 | SVRA | Savara Inc. | 1.29B | -3.96% | 1,204,873 | - |
| 325 | INBX | Inhibrx Biosciences, Inc. | 1.28B | -4.65% | 417,428 | 1.30M |
| 326 | PGEN | Precigen, Inc. | 1.28B | -7.25% | 5,330,704 | 31.60M |
| 327 | TDOC | Teladoc Health, Inc. | 1.27B | -3.56% | 3,343,105 | 2.51B |
| 328 | MPLT | MapLight Therapeutics, Inc. | 1.27B | -6.94% | 478,181 | - |
| 329 | ARDT | Ardent Health, Inc. | 1.24B | 0.93% | 410,936 | 6.43B |
| 330 | HROW | Harrow, Inc. | 1.24B | -4.32% | 647,636 | 268.68M |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.23B | 1.01% | 3,119,366 | 787.08M |
| 332 | AMN | AMN Healthcare Services, Inc. | 1.23B | 3.53% | 1,646,110 | 3.42B |
| 333 | BFLY | Butterfly Network, Inc. | 1.20B | -11.95% | 5,429,216 | 102.92M |
| 334 | IRMD | IRADIMED CORPORATION | 1.19B | -0.76% | 115,765 | 86.28M |
| 335 | INSP | Inspire Medical Systems, Inc. | 1.19B | -2.37% | 724,971 | 915.25M |
| 336 | AVNS | Avanos Medical, Inc. | 1.17B | 0.20% | 823,135 | 715.90M |
| 337 | CDNA | CareDx, Inc. | 1.15B | -3.76% | 548,319 | 412.82M |
| 338 | AHG | Akso Health Group | 1.15B | -8.22% | 13,334 | 14.84M |
| 339 | KMTS | Kestra Medical Technologies, Ltd. | 1.13B | -5.11% | 315,020 | 83.72M |
| 340 | AVLN | Avalyn Pharma Inc. | 1.13B | 0.26% | 327,006 | - |
| 341 | PSNL | Personalis, Inc. | 1.13B | -11.16% | 4,148,751 | 64.52M |
| 342 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | -0.57% | 184,205 | - |
| 343 | ALVO | Alvotech | 1.11B | -5.35% | 693,968 | 562.04M |
| 344 | ZBIO | Zenas BioPharma, Inc. | 1.10B | -4.95% | 494,075 | 10.00M |
| 345 | PNTG | The Pennant Group, Inc. | 1.10B | 5.28% | 236,685 | 1.02B |
| 346 | WVE | Wave Life Sciences Ltd. | 1.10B | -5.91% | 3,979,275 | 71.80M |
| 347 | OPK | OPKO Health, Inc. | 1.09B | -1.37% | 3,947,919 | 581.12M |
| 348 | COLL | Collegium Pharmaceutical, Inc. | 1.08B | 2.11% | 333,286 | 796.33M |
| 349 | SDGR | Schrödinger, Inc. | 1.07B | -9.27% | 1,375,060 | 254.91M |
| 350 | XERS | Xeris Biopharma Holdings, Inc. | 1.07B | 0.49% | 1,057,426 | 314.85M |
| 351 | OMDA | Omada Health, Inc. | 1.07B | -1.54% | 1,066,853 | 283.30M |
| 352 | CNMD | CONMED Corporation | 1.06B | 0.09% | 420,233 | 1.37B |
| 353 | MNKD | MannKind Corporation | 1.05B | -3.41% | 3,245,421 | 360.78M |
| 354 | AZTA | Azenta, Inc. | 1.05B | -0.66% | 1,090,900 | 596.48M |
| 355 | AKTS | Aktis Oncology, Inc. | 1.04B | -5.13% | 138,618 | 8.28M |
| 356 | CRON | Cronos Group Inc. | 1.03B | -2.14% | 2,157,628 | 159.54M |
| 357 | EVO | Evotec SE | 1.01B | -5.72% | 32,060 | 859.03M |
| 358 | NNNN | Anbio Biotechnology | 1.01B | -14.88% | 60,764 | 8.65M |
| 359 | ABSI | Absci Corporation | 997.79M | -12.81% | 5,223,537 | 1.84M |
| 360 | INNV | InnovAge Holding Corp. | 990.88M | 1.39% | 341,350 | 949.17M |
| 361 | EYPT | EyePoint, Inc. | 987.65M | -3.92% | 925,233 | 7.61M |
| 362 | QDEL | QuidelOrtho Corporation | 977.18M | -6.34% | 1,439,576 | 2.66B |
| 363 | AORT | Artivion, Inc. | 976.69M | -3.45% | 554,848 | 458.69M |
| 364 | DBVT | DBV Technologies S.A. | 974.54M | -5.63% | 273,477 | 5.74M |
| 365 | USPH | U.S. Physical Therapy, Inc. | 965.63M | 2.72% | 132,899 | 787.69M |
| 366 | AVR | Anteris Technologies Global Corp. | 949.88M | -0.10% | 1,331,947 | 1.85M |
| 367 | CRVS | Corvus Pharmaceuticals, Inc. | 935.09M | -5.12% | 1,182,124 | - |
| 368 | NUTX | Nutex Health Inc. | 917.73M | -1.28% | 131,507 | 879.95M |
| 369 | PHAR | Pharming Group N.V. | 911.36M | 0.57% | 10,858 | 369.49M |
| 370 | OLMA | Olema Pharmaceuticals, Inc. | 900.55M | -3.46% | 2,519,669 | - |
| 371 | GDRX | GoodRx Holdings, Inc. | 897.49M | -7.02% | 2,116,546 | 787.89M |
| 372 | PCRX | Pacira BioSciences, Inc. | 895.17M | 0.35% | 402,720 | 734.86M |
| 373 | TALK | Talkspace, Inc. | 874.42M | 0.38% | 1,869,067 | 238.37M |
| 374 | XNCR | Xencor, Inc. | 872.65M | -2.00% | 862,474 | 97.36M |
| 375 | SPTX | Seaport Therapeutics, Inc. | 871.78M | -8.05% | 170,721 | - |
| 376 | AMPH | Amphastar Pharmaceuticals, Inc. | 870.39M | 5.56% | 750,284 | 720.53M |
| 377 | ANNX | Annexon, Inc. | 866.73M | -2.94% | 1,762,568 | - |
| 378 | INMD | InMode Ltd. | 857.88M | -0.59% | 490,173 | 374.64M |
| 379 | SPRY | ARS Pharmaceuticals, Inc. | 850.04M | -5.62% | 1,288,222 | 98.99M |
| 380 | LXRX | Lexicon Pharmaceuticals, Inc. | 848.42M | 0.53% | 1,761,548 | 69.64M |
| 381 | DRTS | Alpha Tau Medical Ltd. | 843.15M | -9.14% | 1,390,932 | - |
| 382 | TBPH | Theravance Biopharma, Inc. | 839.80M | -0.49% | 242,785 | 109.78M |
| 383 | ABUS | Arbutus Biopharma Corporation | 839.54M | -2.30% | 1,124,740 | 191.45M |
| 384 | IVA | Inventiva S.A. | 839.46M | -4.73% | 1,083,244 | 7.94M |
| 385 | JBIO | Jade Biosciences, Inc. | 836.16M | -4.51% | 2,600,892 | - |
| 386 | CERT | Certara, Inc. | 835.38M | -4.28% | 5,160,678 | 419.75M |
| 387 | MGTX | MeiraGTx Holdings plc | 833.49M | -5.96% | 693,693 | 79.76M |
| 388 | CGEM | Cullinan Therapeutics, Inc. | 830.30M | -6.38% | 753,801 | - |
| 389 | LBRX | LB Pharmaceuticals Inc | 818.14M | -1.04% | 156,848 | - |
| 390 | LMRI | Lumexa Imaging Holdings, Inc. | 816.69M | 3.28% | 611,324 | 1.03B |
| 391 | JANX | Janux Therapeutics, Inc. | 814.75M | -2.98% | 490,576 | 13.73M |
| 392 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 8,408,767 | 418.24M |
| 393 | PHAT | Phathom Pharmaceuticals, Inc. | 804.63M | 2.74% | 1,157,039 | 204.89M |
| 394 | ETON | Eton Pharmaceuticals, Inc. | 797.94M | 0.80% | 239,301 | 86.93M |
| 395 | REPL | Replimune Group, Inc. | 781.96M | -4.05% | 4,607,813 | - |
| 396 | ORIC | ORIC Pharmaceuticals, Inc. | 776.38M | -6.48% | 1,246,030 | - |
| 397 | KURA | Kura Oncology, Inc. | 775.89M | -0.34% | 3,225,814 | 71.64M |
| 398 | ODTX | Odyssey Therapeutics, Inc. | 775.07M | -3.35% | 389,821 | 2.98M |
| 399 | SSII | SS Innovations International, Inc. | 755.77M | -1.56% | 54,075 | 48.47M |
| 400 | BVS | Bioventus Inc. | 755.15M | 3.91% | 698,271 | 576.30M |
| 401 | GERN | Geron Corporation | 750.58M | -3.31% | 9,600,839 | 196.12M |
| 402 | SANA | Sana Biotechnology, Inc. | 745.82M | -9.46% | 4,682,375 | - |
| 403 | HSTM | HealthStream, Inc. | 737.39M | -0.20% | 185,930 | 311.78M |
| 404 | AURA | Aura Biosciences, Inc. | 731.29M | -2.50% | 347,124 | - |
| 405 | EVMN | Evommune, Inc. | 717.49M | -3.72% | 417,444 | 10.00M |
| 406 | VOR | Vor Biopharma Inc. | 713.08M | -8.10% | 597,319 | - |
| 407 | OMER | Omeros Corporation | 708.55M | -4.49% | 1,717,308 | 9.89M |
| 408 | BIOA | BioAge Labs, Inc. | 697.91M | -7.76% | 376,314 | 10.32M |
| 409 | CBLL | CeriBell, Inc. | 692.45M | -2.67% | 202,493 | 95.07M |
| 410 | AVTX | Avalo Therapeutics, Inc. | 688.61M | -3.75% | 1,757,605 | 59.00K |
| 411 | DRUG | Bright Minds Biosciences Inc. | 677.34M | -7.38% | 712,345 | - |
| 412 | OCS | Oculis Holding AG | 676.95M | -5.24% | 871,780 | 1.40M |
| 413 | SIBN | SI-BONE, Inc. | 670.56M | 1.61% | 378,993 | 206.22M |
| 414 | DSGN | Design Therapeutics, Inc. | 665.17M | -1.02% | 791,213 | - |
| 415 | SLDB | Solid Biosciences Inc. | 659.61M | -7.46% | 701,693 | - |
| 416 | CRMD | CorMedix Inc. | 655.86M | -2.11% | 906,183 | 400.05M |
| 417 | CTMX | CytomX Therapeutics, Inc. | 653.11M | -5.66% | 3,419,595 | 35.54M |
| 418 | ALLO | Allogene Therapeutics, Inc. | 648.89M | -7.84% | 7,989,079 | 22.00K |
| 419 | ANRO | Alto Neuroscience, Inc. | 640.06M | -8.84% | 414,098 | - |
| 420 | CSTL | Castle Biosciences, Inc. | 637.23M | -2.41% | 212,464 | 339.92M |
| 421 | TENX | Tenax Therapeutics, Inc. | 631.76M | -3.25% | 560,365 | - |
| 422 | SGP | SpyGlass Pharma, Inc. | 627.75M | -3.54% | 77,527 | - |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 627.21M | -5.01% | 2,137,592 | 122.29M |
| 424 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 625.64M | -5.10% | 306,636 | - |
| 425 | RLMD | Relmada Therapeutics, Inc. | 624.10M | -5.71% | 1,255,394 | - |
| 426 | CADL | Candel Therapeutics, Inc. | 623.53M | -8.20% | 2,048,368 | - |
| 427 | BBNX | Beta Bionics, Inc. | 618.96M | - | 1,006,979 | 110.24M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 608.93M | -7.43% | 928,945 | 8.37M |
| 429 | CBIO | Crescent Biopharma, Inc. | 598.12M | -2.44% | 192,619 | 11.88M |
| 430 | PHR | Phreesia, Inc. | 589.69M | -1.55% | 1,135,706 | 495.59M |
| 431 | TLRY | Tilray Brands, Inc. | 589.26M | -4.82% | 7,843,022 | 858.28M |
| 432 | BWAY | BrainsWay Ltd. | 584.97M | -2.66% | 107,620 | 56.22M |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 579.21M | -8.79% | 868,752 | - |
| 434 | GYRE | Gyre Therapeutics, Inc. | 574.73M | 1.62% | 137,879 | 117.05M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 572.93M | 0.91% | 200,590 | 343.52M |
| 436 | MDXG | MiMedx Group, Inc. | 557.06M | -1.06% | 1,156,680 | 389.42M |
| 437 | RIGL | Rigel Pharmaceuticals, Inc. | 553.77M | -1.06% | 498,314 | 299.77M |
| 438 | IMMX | Immix Biopharma, Inc. | 553.44M | -5.82% | 1,267,666 | - |
| 439 | PRME | Prime Medicine, Inc. | 552.69M | -11.82% | 4,486,318 | 4.03M |
| 440 | TECX | Tectonic Therapeutic, Inc. | 547.21M | -0.45% | 85,610 | - |
| 441 | IRWD | Ironwood Pharmaceuticals, Inc. | 544.87M | -2.65% | 1,334,361 | 361.51M |
| 442 | FLGT | Fulgent Genetics, Inc. | 543.87M | -1.79% | 374,981 | 320.35M |
| 443 | PROK | ProKidney Corp. | 543.71M | -2.70% | 1,520,164 | 889.00K |
| 444 | CERS | Cerus Corporation | 543.00M | -2.87% | 1,606,724 | 216.56M |
| 445 | DNA | Ginkgo Bioworks Holdings, Inc. | 536.97M | -9.17% | 1,519,613 | 151.40M |
| 446 | NPCE | NeuroPace, Inc. | 536.64M | -3.55% | 134,079 | 99.53M |
| 447 | CABA | Cabaletta Bio, Inc. | 529.93M | -7.41% | 4,288,035 | - |
| 448 | CTKB | Cytek Biosciences, Inc. | 528.19M | -5.54% | 912,389 | 204.17M |
| 449 | XOMA | XOMA Royalty Corporation | 527.85M | -0.73% | 41,947 | 48.56M |
| 450 | ALT | Altimmune, Inc. | 527.02M | -7.19% | 3,129,223 | 36.00K |
| 451 | ACHV | Achieve Life Sciences, Inc. | 526.64M | -3.02% | 770,182 | - |
| 452 | VALN | Valneva SE | 513.32M | -3.35% | 36,900 | 180.25M |
| 453 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 454 | CLYM | Climb Bio, Inc. | 503.96M | -3.30% | 985,563 | - |
| 455 | SRTA | Strata Critical Medical, Inc. | 500.99M | -7.51% | 1,023,029 | 228.58M |
| 456 | ANGO | AngioDynamics, Inc. | 497.68M | -0.75% | 385,739 | 313.73M |
| 457 | AQST | Aquestive Therapeutics, Inc. | 493.02M | -5.07% | 1,234,947 | 50.27M |
| 458 | AGMB | AgomAb Therapeutics NV | 488.54M | -16.57% | 97,772 | - |
| 459 | TOI | The Oncology Institute, Inc. | 486.92M | 2.74% | 4,158,661 | 545.76M |
| 460 | EIKN | Eikon Therapeutics, Inc. | 485.08M | -8.38% | 229,292 | - |
| 461 | ARVN | Arvinas, Inc. | 478.75M | -4.13% | 649,836 | 89.40M |
| 462 | EVH | Evolent Health, Inc. | 474.67M | -3.65% | 2,058,836 | 1.89B |
| 463 | KIDS | OrthoPediatrics Corp. | 470.55M | 1.22% | 93,704 | 243.30M |
| 464 | PRTA | Prothena Corporation plc | 460.18M | -4.97% | 656,302 | 57.94M |
| 465 | ASMB | Assembly Biosciences, Inc. | 453.82M | -5.02% | 130,629 | 71.10M |
| 466 | WEAV | Weave Communications, Inc. | 452.73M | -1.39% | 657,946 | 248.72M |
| 467 | KYTX | Kyverna Therapeutics, Inc. | 452.16M | -6.04% | 617,363 | - |
| 468 | FDMT | 4D Molecular Therapeutics, Inc. | 451.67M | -13.69% | 644,542 | 88.24M |
| 469 | PACB | Pacific Biosciences of California, Inc. | 450.37M | -11.04% | 6,483,634 | 160.03M |
| 470 | LAB | Standard BioTools Inc. | 448.92M | -9.45% | 3,499,528 | 86.26M |
| 471 | OVID | Ovid Therapeutics Inc. | 447.94M | -3.23% | 1,410,873 | 7.12M |
| 472 | RZLT | Rezolute, Inc. | 443.98M | -5.76% | 2,082,632 | - |
| 473 | CTEV | Claritev Corporation | 440.51M | -6.27% | 86,481 | 978.76M |
| 474 | EOLS | Evolus, Inc. | 439.25M | 1.06% | 706,462 | 301.79M |
| 475 | OCGN | Ocugen, Inc. | 433.31M | -6.57% | 5,284,218 | 4.47M |
| 476 | STRO | Sutro Biopharma, Inc. | 432.32M | -9.03% | 295,739 | 99.61M |
| 477 | MYGN | Myriad Genetics, Inc. | 431.63M | -2.56% | 1,153,226 | 829.00M |
| 478 | NRC | NRC Health | 429.77M | -3.44% | 152,453 | 138.64M |
| 479 | CTNM | Contineum Therapeutics, Inc. | 429.38M | -6.93% | 285,368 | - |
| 480 | VREX | Varex Imaging Corporation | 425.26M | -3.54% | 336,781 | 857.50M |
| 481 | CCCC | C4 Therapeutics, Inc. | 424.20M | -7.67% | 2,126,931 | 34.86M |
| 482 | KMDA | Kamada Ltd. | 423.24M | -2.85% | 46,790 | 181.68M |
| 483 | NGNE | Neurogene Inc. | 418.59M | -3.60% | 67,356 | 925.00K |
| 484 | MOBI | Mobia Medical, Inc. | 417.54M | -8.82% | 89,865 | 32.04M |
| 485 | SGMT | Sagimet Biosciences Inc. | 417.44M | -4.25% | 608,349 | - |
| 486 | EBS | Emergent BioSolutions Inc. | 416.38M | -4.38% | 701,550 | 676.80M |
| 487 | OFIX | Orthofix Medical Inc. | 415.94M | -0.48% | 324,760 | 825.37M |
| 488 | EDIT | Editas Medicine, Inc. | 415.88M | -9.36% | 2,366,207 | 38.69M |
| 489 | INDP | Indaptus Therapeutics, Inc. | 414.47M | -22.95% | 2,791,425 | - |
| 490 | CCRN | Cross Country Healthcare, Inc. | 408.69M | -0.08% | 283,298 | 1.00B |
| 491 | AUTL | Autolus Therapeutics plc | 407.20M | -7.83% | 1,461,918 | 92.62M |
| 492 | FBRX | Forte Biosciences, Inc. | 403.68M | -0.96% | 408,707 | - |
| 493 | VTVT | vTv Therapeutics Inc. | 398.84M | -6.43% | 39,951 | 36.84M |
| 494 | MNPR | Monopar Therapeutics Inc. | 398.44M | 0.29% | 193,321 | - |
| 495 | ANL | Adlai Nortye Ltd. | 398.00M | -7.45% | 147,124 | 5.00M |
| 496 | CGC | Canopy Growth Corporation | 393.83M | -0.96% | 13,451,076 | 203.04M |
| 497 | EPRX | Eupraxia Pharmaceuticals Inc. | 390.81M | -7.75% | 356,564 | - |
| 498 | CLPT | ClearPoint Neuro, Inc. | 386.57M | -9.99% | 625,867 | 40.61M |
| 499 | TBRG | TruBridge, Inc. | 385.68M | - | 413,727 | 345.90M |
| 500 | CNXU | Conexeu Sciences Inc. | 385.23M | -4.72% | 35,515 | - |